TBPH
Theravance Biopharma Inc
Halal Rating :
Last Price
$8.58
Last updated:
Market Cap
-
7D Change
0.12%
1 Year Change
-11.18%
Company Overview
Industries
Exchange
Next Earnings Date
Theravance Biopharma Inc is a biopharmaceutical company focused on discovering, developing, and commercializing organ-selective medicines. The company's primary focus is on developing medicines for respiratory conditions, gastrointestinal diseases, and other health conditions.
The company's business model revolves around research, development, and commercialization of novel therapeutics. Their revenue primarily comes from collaboration agreements, licensing deals, and royalties from their developed medications.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $16.87m | $28.34m | - | $630000.0 | 0.00% | 2.22% |
| June 30, 2024 | $14.26m | $30.61m | - | $644000.0 | 0.00% | 2.10% |
| March 31, 2024 | $14.5m | $26.34m | - | $629000.0 | 0.00% | 2.39% |
Company Impact
Help us evaluate Theravance Biopharma Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.